Senior Director/Director, FP&A and R&D Finance

Sorry, this job was removed at 08:18 p.m. (UTC) on Monday, Mar 16, 2026
Be an Early Applicant
Bothell, WA, USA
In-Office
211K-303K Annually
Biotech • Pharmaceutical
The Role

Company Overview

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

We are seeking a Senior Director/Director to lead the R&D Finance function, which serves as the primary finance business partner to R&D leadership within our Finance organization. The role oversees a hybrid finance and accounting team responsible for accruals, internal reporting, budgeting and forecasting, and strategic financial support across our Research, Technical Operations, and Development organizations.

This is a high-impact leadership role that combines a strong understanding of US GAAP accounting with forward-looking FP&A capabilities and a strategic mindset to drive financial performance management and decision support across R&D. The role will partner closely with Finance leadership, including the Controller and the Director of FP&A and Commercial Finance, as well as with leaders across the R&D organization. The role will be expected to build and scale the R&D Finance team as Immunome’s pipeline grows and matures.

Responsibilities

R&D Financial Leadership & Business Partnership

  • Lead the R&D Finance function, serving as the primary finance business partner to R&D leadership across Research, Technical Operations, and Development.
  • Define and execute an effective R&D Finance partnership model that supports financial insight, decision-making, and performance management.
  • Oversee preparation of internal R&D financial reporting, including variance analysis, budget-to-actuals for cash burn and GAAP activity, and executive-level summaries.
  • Develop a deep understanding of the activities, timelines, and cost drivers underlying drug discovery, clinical development, and technical operations in order to deliver clear financial analysis and support executive-level decision making.

Budgeting, Forecasting & Strategic Planning

  • Lead R&D budgeting, forecasting, and long-range planning in partnership with Project Management and R&D leadership.
  • Develop and maintain detailed program-level and functional forecasts, including robust clinical trial forecasts based on timelines, enrollment assumptions, and cost drivers.
  • Ensure R&D plans are translated into accurate, forward-looking financial forecasts that support decision-making, scenario analysis, and alignment with enterprise financial objectives.

R&D Accounting & Accruals

  • Lead monthly accrual tracking and review for significant R&D spend areas, including clinical trials, CROs, and other program-level expenses, as needed.
  • Review and approve key monthly journal entries related to R&D spend, ensuring compliance with US GAAP and internal accounting policies.
  • Partner closely with Accounting to ensure timely, accurate close processes and adherence to SOX controls.
  • Support external reporting and audit activities by providing documentation, analysis, and commentary related to R&D and clinical trial spend.

Team Leadership & Cross-Functional Collaboration

  • Build, lead, and develop the R&D Finance team, establishing clear roles, expectations, and development plans as the organization and pipeline scale.
  • Collaborate cross-functionally with Finance and R&D leadership to ensure alignment across financial planning, reporting, accruals, and performance management.
  • Serve as a key finance participant in cross-functional initiatives to build scalable processes, systems, and infrastructure as the company grows and matures.
  • Drive cross-functional alignment around assumptions, timelines, and financial implications for R&D programs to ensure consistent planning and communication.

Qualifications

  • Bachelor’s degree in Finance, Accounting, or related field; CPA and/or MBA preferred.
  • A minimum of 10 years of progressive experience in finance and/or accounting roles, with significant experience supporting R&D organizations in the life sciences or biotechnology industry.

Knowledge and Skills

  • Demonstrated experience leading finance activities that integrate financial planning, analysis and reporting, accounting oversight, and effective business partnership in a dynamic and growing organization.
  • Strong understanding of US GAAP as it relates to R&D accounting, accruals, and complex vendor and clinical trial contracts.
  • Ability to understand, evaluate, and report on financial information using both GAAP and cash accounting methodologies
  • Strong business partnering skills with the ability to effectively collaborate with and influence stakeholders across all levels of the organization and a wide range of functional areas.
  • Proven leadership skills with experience managing small teams, multiple stakeholders, and leading cross-functional initiatives.
  • Ability to develop a deep understanding of scientific, clinical, and technical drivers across the R&D lifecycle and translate them into clear financial insights.
  • Excellent communication and presentation skills, with the ability to convey complex financial information to senior management.
  • Self-directed leader who thrives in a fast-paced, evolving environment and can balance strategic thinking with strong execution and attention to detail.
  • Proficiency with financial planning/reporting software and ERP systems; Experience with NetSuite, Vena, and working with data from clinical trial planning and management systems is a plus
Washington State Pay Range
$211,105$303,020 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).

Similar Jobs

CDW Logo CDW

Consultant

Information Technology
Remote or Hybrid
US
15100 Employees
156K-241K Annually

Liberty Mutual Insurance Logo Liberty Mutual Insurance

Auto Claims Desk Adjuster Hybrid - Liberty Lake, WA

Artificial Intelligence • Fintech • Insurance • Marketing Tech • Software • Analytics
Hybrid
Liberty Lake, WA, USA
40000 Employees
46K-84K Annually

Liberty Mutual Insurance Logo Liberty Mutual Insurance

Data Steward: Personal Lines Product, Pricing and Underwriting data domain

Artificial Intelligence • Fintech • Insurance • Marketing Tech • Software • Analytics
Remote or Hybrid
7 Locations
40000 Employees
120K-225K Annually

HiBob Logo HiBob

Sales Engineer

HR Tech • Information Technology • Professional Services • Sales • Software
Remote or Hybrid
United States
1350 Employees
90K-120K Annually
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Bothell, Washington
180 Employees

What We Do

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees
Cencora Thumbnail
Healthtech • Logistics • Pharmaceutical
Conshohocken, PA
51000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account